Skip to main content
Nancy Kemeny, MD, Oncology, New York, NY

NancyEKemenyMD

Oncology New York, NY

Attending Physician, Memorial Sloan-Kettering Cancer Center

Dr. Kemeny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kemeny's full profile

Already have an account?

  • Office

    Memorial Sloan Kettering Cancer Center New York
    1275 York Avenue
    New York, NY 10021

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1974 - 1976
  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Internal Medicine, 1971 - 1974
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1971

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License Active through 2025
  • NY State Medical License
    NY State Medical License 1972 - 2025
  • VT State Medical License
    VT State Medical License 2022 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases  
    Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology

Lectures

  • Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal canc... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Doctors Fret as Firm Stops Making Cancer Drug Pump
    Doctors Fret as Firm Stops Making Cancer Drug PumpApril 26th, 2018
  • Liver-Directed Therapy Shows Improvement in mCRC
    Liver-Directed Therapy Shows Improvement in mCRCJanuary 5th, 2018

Grant Support

  • Therapy Of Hepatic Metastases From Colorectal CarcinomaNational Cancer Institute1993–2001
  • ST Vincent'S Community Clinical Oncology ProgramNational Cancer Institute1987–1989

Professional Memberships